G Görétzlehner
No ORCID on file
· 11 papers in corpus
· active 1985-2009
Study types
- article 11
Condition tags
- endometriosis 4
- die_deep_infiltrating 2
Top journals
Frequent coauthors
- Günter Köhler 5
- J Lembke 2
- Ulf Göretzlehner 2
- S Lembke 2
- J. Meißner 1
- K Angelow 1
- K Brachmann 1
- K Rudolf 1
- K Schollberg 1
- M Rüting 1
article
2009
Estradiol-17 beta, progesterone, LH and FSH levels in plasma were measured simultaneously by radioimmunoassay and BBT was recorded in order to investigate the effect of a single midcycle oral dose of 0.5 or 2.0 mg dienogest (17 alpha-cyanom…
article
2008
Die Hormontherapie der Endometriose ist mit GnRH-Analoga, oralen hormonalen Kontrazeptiva (Mikropillen mit einer Ethinylestradiol-Dosis ≤30 µg und einem Gestagen) und Gestagenen möglich. Unmittelbar nach der histologischen Sicherung d…
article
2003
Dienogest (17-alpha-Cyanomethyl-17b-hydroxy-4,9-estradien-3-on (DNG)) vereinigt die Vorzüge der 19-Nortestosteron-Derivate (Norgestagene) mit den typischen Eigenschaften der 17-alpha-Hydroxyprogesteron-Derivate. Dienogest ist der erste Repr…
article
2000
article
1996
Kupperman-index, weight, blood pressure, serum lipids, blood count, thrombocytes, fibrinogen, thrombine time, electrolytes, enzymes, serum proteins, bilirubine and other parameters were studied in 16 healthy post-menopausal women treated fo…
article
1989
The effects of a new progestational compound, dienogest (17 alpha-cyanomethyl-17 beta-hydroxy-estra-4,9-dien-3-one) on lipid metabolism have been studied in 84 otherwise healthy women with laparoscopically proven endometriosis. The women, a…
article
1988
In a survey it is reported on the antiprogestins mifepristone (RU 486) and gestrinone (R 2323). Thanks to its high reversible affinity for progesterone receptor mifepristone stops progesterone activity at its target organs. Mifepristone als…
article
1988
The pharmacology and the application in oral hormonal contraceptives of four new progestogens--gestodene, desogestrel, norgestimate, and dienogest--are described in a survey. Although derived from 19-norethisterone these progestogens exhibi…
article
1987
Dienogest (17 alpha-cyanomethyl-17 beta-hydroxy-estra-4,9-dien-3-one, VEB Jenapharm, Jena, GDR), an orally active 19-nortestosterone derivative, was used firstly in the treatment of endometriosis. 57 patients (age 17-45 years) have been ent…
article
1986
The authors supply a survey about the aetiology varied classification systems and the hormontherapy of endometriosis. We have described the advantages and disadvantages of the therapy with progestagens, danazol, gestrinon and Gn RH agonists…
article
1985